CTO0308 for myopia

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 11 Aug 2025: Trial started, NCT07790640
  2. 27 Aug 2026: Trial registered, NCT07790640

The trials

NCT07790640: Evaluate the Efficacy and Safety of CTO0308 in Pediatric Patients With Myopia

State
Under way
Phase
Phase 3
People
351 taking part
Started
11 Aug 2025
Primary completion
1 Apr 2027
Arms
CTO0308-A, CTO0308-B, CTO0308-C
Results
None posted
  1. 11 Aug 2025: Trial started
  2. 27 Aug 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.